Literature DB >> 9309192

Lymphocytes, cytokines, inflammation, and immune trafficking.

G C Tsokos1, B Kovacs, S N Liossis.   

Abstract

Studies reported during the past year have added new knowledge to our understanding of the pathogenesis of systemic lupus erythematosus. A study of sibpairs with lupus revealed a strong linkage of a region located at chromosome 1q41-42 that crossed ethnic barriers. B-cell receptor-initiated signaling events, such as tyrosine protein phosphorylation and intracellular calcium concentrations, were found to be increased in patients with lupus in a disease- and clinical activity-independent manner. T cells from patients with lupus express increased amounts of the CD40 ligand, which is functional because it helps B cells to produce anti-DNA antibodies and express more CD80 (B7-1) on their surface. Only occasionally do lupus patients display structural defects of either Fas antigen or ligand molecules, and although spontaneous apoptosis is increased in lupus cells (as well as in other systemic autoimmune disorders), the activation-induced T-cell death is defective.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9309192     DOI: 10.1097/00002281-199709000-00002

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  3 in total

1.  Serum levels of soluble Fas ligand in patients with silicosis.

Authors:  A Tomokuni; T Otsuki; Y Isozaki; S Kita; H Ueki; M Kusaka; T Kishimoto; A Ueki
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

2.  Detection of anti-topoisomerase I autoantibody in patients with silicosis.

Authors:  Akiko Tomokuni; Takemi Otsuki; Haruko Sakaguchi; Yumika Isozaki; Fuminori Hyodoh; Masayasu Kusaka; Ayako Ueki
Journal:  Environ Health Prev Med       Date:  2002-04       Impact factor: 3.674

3.  The cyclic AMP response element modulator {alpha} suppresses CD86 expression and APC function.

Authors:  Martina Ahlmann; Georg Varga; Karsten Sturm; Ralph Lippe; Konrad Benedyk; Dorothee Viemann; Thomas Scholzen; Jan Ehrchen; Frank U Müller; Matthias Seidl; Marek Matus; George C Tsokos; Johannes Roth; Klaus Tenbrock
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.